MetaCap

ImmunityBio Statistics

NASDAQ: IBRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

6.02-0.55 (-8.37%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ImmunityBio by the numbers

ImmunityBio has a market capitalization of $6.40 billion based on 1.06B shares outstanding. With trailing EPS of $-1.06, ImmunityBio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.5% below its 50-day average and 24.5% below its 200-day average.

Average daily trading volume is 12.97M shares, or about $78.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IBRX valuation vs. peer median

IBRX compared with the median of 8 peer companies
MetricIBRXPeer medianDifference
Market cap$6.40B$6.46B-1%
Avg. volume12.97M1.82M+614%

Peer median across 8 companies: KOD, IMVT, SRRK, TWST, CGON, ADPT, PCVX, CRSP.

Valuation

Price / sales (latest FY)
56.53
EPS (TTM)
$-1.06

Price and trading

Previous close
6.57
Open
6.41
Day range
6.00 – 6.53
52-week range
1.95 – 12.43
52-week change
+189.42%
Beta
—
Volume
10.57M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
6.40B
Forward Pe
-20.07
Eps
-1.06
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
12.43
Week52 Low
1.95
Avg Volume
12.97M
Shares Outstanding
1.06B
Ma50
8.42
Ma200
7.98
Earnings Date
Nov 9, 2026
Pct From52w High
-51.57%
Pct From52w Low
208.72%

Related